Literature DB >> 12057761

The iron regulatory proteins: targets and modulators of free radical reactions and oxidative damage.

Gaetano Cairo1, Stefania Recalcati, Antonello Pietrangelo, Giorgio Minotti.   

Abstract

Iron acquisition is a fundamental requirement for many aspects of life, but excess iron may result in formation of free radicals that damage cellular constituents. For this reason, the amount of iron within the cell is carefully regulated in order to provide an adequate level of a micronutrient while preventing its accumulation and toxicity. A major mechanism for the regulation of iron homeostasis relies on the post-transcriptional control of ferritin and transferrin receptor mRNAs, which are recognized by two cytoplasmic iron regulatory proteins (IRP-1 and IRP-2) that modulate their translation and stability, respectively. IRP-1 can function as a mRNA binding protein or as an aconitase, depending on whether it disassembles or assembles an iron-sulfur cluster in response to iron deficiency or abundancy, respectively. IRP-2 is structurally and functionally similar to IRP-1, but does not assemble a cluster nor exhibits aconitase activity. Here we briefly review the role of IRP in iron-mediated damage induced by oxygen radicals, nitrogen-centered reactive species, and xenobiotics of pharmacological and clinical interest.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12057761     DOI: 10.1016/s0891-5849(02)00825-0

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  39 in total

1.  Deferiprone reduces amyloid-β and tau phosphorylation levels but not reactive oxygen species generation in hippocampus of rabbits fed a cholesterol-enriched diet.

Authors:  Jaya R P Prasanthi; Matthew Schrag; Bhanu Dasari; Gurdeep Marwarha; April Dickson; Wolff M Kirsch; Othman Ghribi
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  Molecular control of vertebrate iron homeostasis by iron regulatory proteins.

Authors:  Michelle L Wallander; Elizabeth A Leibold; Richard S Eisenstein
Journal:  Biochim Biophys Acta       Date:  2006-05-17

Review 3.  Metabolite sensing in eukaryotic mRNA biology.

Authors:  Carina C Clingman; Sean P Ryder
Journal:  Wiley Interdiscip Rev RNA       Date:  2013-05-07       Impact factor: 9.957

4.  Possible therapeutic impact of the iron chelation on renal fibrosis.

Authors:  Kouichi Tamura; Kazushi Uneda; Kengo Azushima; Hiromichi Wakui; Kotaro Haruhara
Journal:  Hypertens Res       Date:  2015-04-16       Impact factor: 3.872

Review 5.  Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability.

Authors:  Roberto Rodrigues; Robert B Petersen; George Perry
Journal:  Cell Mol Neurobiol       Date:  2014-06-14       Impact factor: 5.046

6.  Antioxidant enzymes status and reproductive health of adult male workers exposed to brick kiln pollutants in Pakistan.

Authors:  Sarwat Jahan; Samreen Falah; Hizb Ullah; Asad Ullah; Naveed Rauf
Journal:  Environ Sci Pollut Res Int       Date:  2016-03-21       Impact factor: 4.223

7.  Inhibition of transferrin receptor 1 transcription by a cell density response element.

Authors:  Jian Wang; Guohua Chen; Kostas Pantopoulos
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

8.  Angiotensin II alters the expression of duodenal iron transporters, hepatic hepcidin, and body iron distribution in mice.

Authors:  Soichiro Tajima; Yasumasa Ikeda; Hideaki Enomoto; Mizuki Imao; Yuya Horinouchi; Yuki Izawa-Ishizawa; Yoshitaka Kihira; Licht Miyamoto; Keisuke Ishizawa; Koichiro Tsuchiya; Toshiaki Tamaki
Journal:  Eur J Nutr       Date:  2014-08-07       Impact factor: 5.614

9.  A precious metal: Iron, an essential nutrient for all cells.

Authors:  G Cairo; F Bernuzzi; S Recalcati
Journal:  Genes Nutr       Date:  2006-03       Impact factor: 5.523

Review 10.  Iron-regulatory proteins: molecular biology and pathophysiological implications.

Authors:  Gaetano Cairo; Stefania Recalcati
Journal:  Expert Rev Mol Med       Date:  2007-12-05       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.